State-backed vaccine developer Biovac is in discussion with several pharmaceutical companies developing Covid-19 vaccines to potentially manufacture shots in SA, CEO Morena Makhoana said on Thursday.

The public-private partnership was established in 2003 to revive SA’s human vaccine manufacturing capabilities, with the state owning 47.5% and the majority stake held by a private consortium led by Immunotek. Earlier in November it began manufacturing Sanofi Pasteur’s six-in-one paediatric vaccine Hexaxim, the first time since the mid-1990s that sterile human vaccines have been made in SA...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now